0001375151-19-000019.txt : 20190305 0001375151-19-000019.hdr.sgml : 20190305 20190305160941 ACCESSION NUMBER: 0001375151-19-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190301 FILED AS OF DATE: 20190305 DATE AS OF CHANGE: 20190305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GARNER CAM L CENTRAL INDEX KEY: 0001024007 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34962 FILM NUMBER: 19658395 MAIL ADDRESS: STREET 1: PO BOX 675866 CITY: RANCHO SANTE FE STATE: CA ZIP: 92067 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZOGENIX, INC. CENTRAL INDEX KEY: 0001375151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205300780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 550-8300 MAIL ADDRESS: STREET 1: 5858 HORTON STREET, #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: ZOGENIX INC DATE OF NAME CHANGE: 20060911 4 1 wf-form4_155182016716604.xml FORM 4 X0306 4 2019-03-01 0 0001375151 ZOGENIX, INC. ZGNX 0001024007 GARNER CAM L C/O ZOGENIX, INC. 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608 1 0 0 0 Common Stock 2019-03-01 4 M 0 6250 15.52 A 6250 D Common Stock 2019-03-01 4 M 0 9000 12.80 A 15250 D Common Stock 2019-03-01 4 S 0 15250 50 D 0 D Common Stock 40843 I By Garner Investments, LLC Stock Option (Right to Buy) 15.52 2019-03-01 4 M 0 6250 0 D 2024-05-20 Common Stock 6250.0 0 D Stock Option (Right to Buy) 12.8 2019-03-01 4 M 0 9000 0 D 2025-06-17 Common Stock 9000.0 0 D The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. The option was granted on May 21, 2014 and vests in a series of twelve (12) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date. The option was granted on June 18, 2015 and vests in a series of twelve (12) successive, equal monthly installments measured from the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date. /s/ Thomas Doyle, Attorney-in-fact for Cam L. Garner 2019-03-04